PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION
PetVivo Holdings Inc (PETV) (Q1 2027) Earnings Call Highlights: Revenue Growth and Strategic ...
PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027
PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript
PetVivo Holdings Q1 EPS $(0.05) Up From $(0.10) YoY, Sales $337.572K Up From $297.500K YoY
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM
PetVivo Reaches Settlement With VetStem, Terminates PrecisePRP License Agreement; PetVivo's Sole Remaining Financial Obligation Under The Settlement Agreement Is The Payment Of An Aggregate Of $75,000, Consisting Of Two Scheduled Cash Payments
PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record
PetVivo Holdings Announces Peer-Reviewed Data Publication For Spryng Canine Osteoarthritis And Cranial Cruciate Ligament Disease Treatment
Transcript: PetVivo Hldgs Q4 2026 Earnings Conference Call
PetVivo Holdings Inc (PETV) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
PetVivo Reports Financial and Operational Results for Fiscal 2026
PetVivo Hldgs Q4 EPS $(0.11), Same YoY, Sales $254.715K Up From $224.750K YoY
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform
PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th
PetVivo Holdings (OTCQX:PETV) Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer Program
PetVivo Holdings, Inc. to Host Virtual Investor Event
PTOP's AI Partner Tier 1 AI, Signs Contract With OTCQX:PETV as Enterprise Client
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.